Indaptus Therapeutics (INDP) SC 13D Indaptus Therapeutics / Lee Hoonmo ownership change

Exhibit 99.2

Agreement of Joint Filing

The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

Date: August 13, 2021
	By:	/s/ Hoonmo Lee
	Name:	Hoonmo Lee
	TY Bio Investments, Inc.
	By:	/s/ Hoonmo Lee
	Name:	Hoonmo Lee
	Title:	Secretary and Chief Financial Officer